AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04851145 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Mass spectrometry-based proteomics of FFPE biopsies and urine samples
Description: The biopsy and urine samples will be processed by the OncoProt platform (University of Bordeaux) for proteomic analysis by tandem mass spectrometry (label-free quantification) as follows:~* Biopsies: laser microdissection of the renal cortex, fixation reversion, protein extraction and electrophoretic migration, tryptic digestion.~* Urines: samples concentration by centrifugation/filtration and tryptic digestion according to a protocol adapted from the FASP method (Filter-Aided Sample Preparation)
Study NCT06565494 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: midomafetamine (MDMA)-Assisted Therapy
Description: This treatment consists 3 Preparation sessions followed by 3 Experimental sessions at 4-week intervals; after each Experimental session, 3 weekly Integration sessions will be conducted. For the first Experimental Session, the dose of MDMA is 80 mg; for the second and third Experimental Sessions, the dose of MDMA is 120 mg. For all three Experimental sessions, a supplemental dose of 50% of the initial dose will be available. The Preparation, Experimental, and Integration Sessions will involve psychotherapy developed specifically for this trial and population.
Study NCT06188078 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control
Description: Babies in the control group will be fed only breast milk or formula, and a urine bag will be inserted after 25 minutes and they will be expected to urinate. The success of the transaction and the processing time will be recorded.
Study NCT06188078 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The bladder stimulation technique
Description: Newborns will be fed formula or pumped breast milk, depending on the baby's age and weight. A urine bag will be inserted 25 minutes after the feeding.~The newborn will be held under the armpit by the nurse, male infants will be held with their legs hanging down, and female infants will be held in the hip flexion position.~Newborns with spontaneous voiding during the period from the beginning of the investigation procedure to positioning the newborn will be excluded from the study.~The bladder stimulation technique will be repeated sequentially for 3 minutes until voiding begins.The success of the transaction and the processing time will be recorded.
Study NCT06188078 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Bath
Description: Newborns will be fed formula or pumped breast milk, depending on the baby's age and weight. Babies will be bathed under running water 20 minutes after feeding.The bathing process will take 4 minutes in total. After bath, a urine bag will be inserted at the 25th minute of feeding. The success of the transaction and the processing time will be recorded.
Study NCT06557642 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Entonox
Description: 30 minute inhalation using demand valve and mouthpiece
Study NCT06557642 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Medical Air
Description: 30 minute inhalation using demand valve and mouthpiece
Study NCT04862169 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: educational intervention (SPARK)
Description: There are 3 modules with 11 chapters. These topics were considered as the most relevant topics for implementation of palliative care for PHC nurses. Also, topics were selected based on our previous literature review of the previous study on the content of PHC nurses training program.~The first module is the introduction. This consists of three chapters: introduction, support system and effective communication. Total reading time is estimated to be one hour. The second module is about the nursing approach in palliative care. It is estimated to be completed in around 2 hours and 15 minutes. The last module is about end of life care.~The participants are expected to access this module before the scheduled synchronous mode. Modules will be provided in the electronic version, so that participants are able to download and read them on their own devices. We are also providing video as trigger for case study discussion
Study NCT04862169 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: electronic version of the modules
Description: electronic version of the modules
Study NCT04542486 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Excision of gingival hyperplasia using Soft tissue trimmer .
Description: Gingivoplasties and removal of excess gingival tissues using Soft tissue trimmer.
Study NCT04542486 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Excision of gingival hyperplasia using the conventional scalpel technique
Description: Excision of gingival hyperplasia in gingivoplasties using the conventional technique reverse bevel using 15c blade.
Study NCT06640075 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Community co-produced action
Description: Participatory workshops will be conducted with community members by a multidisciplinary team with the aim to co-develop a strategy for cervical cancer screening adapted to the local setting (including primary HPV screening, triage of HPV-positive patients and treatment of patients triaged positive). This intervention is referred to as 'community co-produced action'. Possible strategies co-developed may include collaboration with community health workers or local associations, awareness campaigns, development of health education materials, integration of primary HPV screening at local integrated health centers, organization of group transportation to the district screening center, etc.~Using purposive sampling methods, approximately 15 participants will be invited to take part in the workshops in each health area of the intervention, including approximately 3 health care providers, 3 community health workers or members of women's associations, 3 men and 6 eligible women for screening.
Study NCT06640075 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard screening strategy
Description: Recruitment of study participants will be coordinated centrally at district level (from the Bafoussam Regional Hospital) following procedures previously established in a cervical cancer screening program in the health district of Dschang. This standard procedure includes the training of 2 community health workers (CHW) by health area to raise awareness around cervical cancer. After an initial theoretical and practical training in cervical cancer prevention, CHWs recruit women by going door-to-door or through community meetings in their respective health areas. Through a system of nominal invitation vouchers distributed to eligible women, CHWs receive a financial incentive for each woman that shows up for cervical cancer screening. Twice a year, CHWs of all health areas are invited to a feedback session to discuss difficulties encountered on the field and propose solutions to face any identified challenges.
Study NCT05675839 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Film (Wit) and a documentary (First Turkish Nurse-Safiye Hüseyin Elbi's Life)
Description: Film (Wit) (https://www.youtube.com/watch?v=2s4ozvI_hzY\&t=160s) and a documentary (First Turkish Nurse-Safiye Hüseyin Elbi's Life) (https://www.youtube.com/watch?v=XsabHOiF0CY\&t=284s)
Study NCT05942573 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Serplulimab+Paclitaxel+Apatinib
Description: Immunotherapy+chemotherapy
Study NCT05942573 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel±Ramucirumab
Description: chemotherapy±Targeted therapy
Study NCT05382390 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: rhTPO
Description: decitabine (15 mg/m2 daily, days 1-5); low-dose cytarabine (10 mg/m2 q12 h, days 3-9); rhTPO (15,000 U daily, days 2, 4, 6, 8, and 10-24 or until a platelet count > 50 × 109/L was observed); aclarubicin (14 mg/m2 daily, days 3-6); and G-CSF (300 μg daily, days 2-9).
Study NCT05382390 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Decitabine
Description: decitabine (15 mg/m2 daily, days 1-5); low-dose cytarabine (10 mg/m2 q12 h, days 3-9); aclarubicin (14 mg/m2 daily, days 3-6); and G-CSF (300 μg daily, days 2-9).
Study NCT05382390 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Decitabine
Description: decitabine (15 mg/m2 daily, days 1-5); low-dose cytarabine (10 mg/m2 q12 h, days 3-9); aclarubicin (14 mg/m2 daily, days 3-6); and G-CSF (300 μg daily, days 2-9).
Study NCT05545553 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Piezosurgery
Description: Piezosurgery used as an osteotomy device
Study NCT05545553 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional burs
Description: Conventional burs used as an osteotomy device
Study NCT06321406 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: NMES (neuromuscular electrical stimulation)
Description: With this application, swallowing muscles are stimulated and muscle strength increases.
Study NCT06321406 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Exercise
Description: Traditional Conservative swallowing treatment
Study NCT05442983 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PanCytoVir™ (probenecid)
Description: Active drug
Study NCT05442983 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo
Study NCT05806359 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Danicamtiv
Description: Specified dose on specified days
Study NCT05806359 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Specified dose on specified days
Study NCT05533268 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mental training
Description: Mental training (guided mindfulness meditation by Jon Kabat-Zinn for 20 minutes, 3 times per week.
Study NCT05533268 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical training
Description: Physical training (continuous moderate-intensity training at 40-60% of participants' heart rate reserve for 20 minutes excluding warm-up/cool-down, 3 times per week.
Study NCT05533268 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mental & physical training
Description: Mental and physical training (combination of mindfulness mediation for 20-minutes, 3 times per week and continuous moderate-intensity training for 20 minutes, 3 times per week.
Study NCT05533268 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: DASH diet
Description: DASH diet ( (more vegetables, fruits and low-fat dairy foods and moderate amounts of whole grains, fish, poultry and nuts; and less than 3 grams of sodium daily) for 6-weeks.
Study NCT05450510 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Accelerated (ACCEL) protocol group
Description: After randomization and initial evaluations, patients will be referred to Physiotherapy and Rehabilitation clinics for a 8-week-long Phase 2 and Phase 3 trainings.
Study NCT05450510 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Slow (SLOW) protocol group
Description: After randomization and initial evaluations, patients will be referred to Physiotherapy and Rehabilitation clinics for a 14-week-long Phase 2 and Phase 3 trainings.
Study NCT06304766 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Laparoscopic ablation
Description: Heat-based ablation modality performed by laparoscopy. Centers may use either radiofrequency or microwave ablation. The modality should be the same in both groups.
Study NCT06304766 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Open ablation
Description: Heat-based ablation modality performed by laparotomy. Centers may use either radiofrequency or microwave ablation. The modality should be the same in both groups.
Study NCT05268679 — intervention group
Intervention type: OTHER
Intervention: Biospecimen Collection
Description: A blood of a sample of 2 x 7 mL will be collected for the analysis of the anti-SARS-CoV-2 T-cell response during a scheduled check-up as part of their routine follow-up
Study NCT05268679 — intervention group
Intervention type: OTHER
Intervention: Questionnaire
Description: Patients who have received SARS-CoV-2 vaccination will be asked to complete the Vaccine tolerance questionnaire
Study NCT05268679 — intervention group
Intervention type: OTHER
Intervention: Electronic Health Record Review
Description: For heart transplant recipients who were offered vaccination against SARS-CoV-2 medical records will be reviewed retrospectively.
Study NCT06198491 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Misbeliefs about HPV training
Description: Intervention trainings mentioned false beliefs before or after the current knowledge
Study NCT04747353 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Catheter ablation procedure with heart 3D model
Description: Device: Catheter ablation procedure performed as part of standard care, although with the addition of an image-based 3D heart model including detailed anatomy and primary ablation targets
Study NCT06106204 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ROAD Home Intervention
Description: Hospitals randomized to receive the ROAD Home Intervention will undergo (1) a baseline needs assessment to create a customized suite of stewardship strategies, (2) supported decision-making in selecting ROAD Home strategies to implement, and (3) external facilitation following an implementation blueprint.
Study NCT05360446 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Inclisiran sodium 300 mg
Description: Subcutaneously administered on Days 1, Month 3 (Day 90), and every 6 months thereafter.
Study NCT05360446 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Subcutaneously administered on Day 1, Month 3 (Day 90), and every 6 months thereafter.
Study NCT06099379 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ∆9-tetrahydrocannabinol
Description: Phytocannabinoids from plant inflorescences (CBD and THC dominant) - inhaled
Study NCT06478979 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Neuclare
Description: It is used to stimulate the brain for a certain period of time to assess gait improvement in patients with Idiopathic Normal Pressure Hydrocephalus (iNPH). In this clinical trial, it is used for patients with Idiopathic Normal Pressure Hydrocephalus (iNPH).
Study NCT05604547 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Non-Invasive Infrared Spectroscopy
Description: NIRS is a non-Invasive optical technique for characterizing microvascular hemodynamics.
Study NCT05967728 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Remote ischemic conditioning (RIC) progammable device
Description: RIC induces brief periods of ischemia-reperfusion in a limb. In our study, this is accomplished using a new device that can be remotely programmed to deliver either true RIC or a sham protocol, with remote monitoring capabilities to track completion of treatment sessions.
Study NCT05967728 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Remote ischemic conditioning (RIC) progammable device
Description: RIC induces brief periods of ischemia-reperfusion in a limb. In our study, this is accomplished using a new device that can be remotely programmed to deliver either true RIC or a sham protocol, with remote monitoring capabilities to track completion of treatment sessions.
Study NCT05856162 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ENRICH pilot intervention (full intervention)
Description: The full ENRICH pilot intervention will consist of content related to diet, physical activity, stress/mental health, sleep, tobacco cessation, and child health. The investigators will use an adapted version of the Mothers and Babies stress management intervention to address mental health, an adapted version of the HEALTH curriculum to address diet/physical activity, and an adapted version of the INSIGHT curriculum to address child health.
Study NCT05856162 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: ENRICH pilot intervention (partial intervention: only diet and physical activity)
Description: The partial ENRICH intervention will focus only on diet and physical activity.
Study NCT06647550 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HD-6277 100mg
Description: PO, QD
Study NCT06647550 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HD-6277 50mg
Description: PO, QD
Study NCT06647550 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HD-6277 25mg
Description: PO, QD
Study NCT06647550 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: PO, QD
Study NCT06654323 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Intensive Behavioral Lifestyle Modification
Description: Participants in all arms will receive visits with their child's primary care provider (4 visits, 1 hour total), on-demand web-based learning modules that focus on building skills and knowledge in health behaviors (7 hours), and community resource counseling sessions delivered by a social worker or similar healthcare professional (4 sessions, 2 hours total). The difference between arms will be in the frequency and duration of personalized nutrition counseling delivered by a registered dietitian or similar healthcare professional: 16 sessions (60 minutes per session), 12 sessions (60 minutes per session), 9 sessions (60 minutes per session), 8 sessions (45 minutes per session), or 6 sessions (30 minutes per session).
Study NCT06654323 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intensive Behavioral Lifestyle Modification
Description: Participants in all arms will receive visits with their child's primary care provider (4 visits, 1 hour total), on-demand web-based learning modules that focus on building skills and knowledge in health behaviors (7 hours), and community resource counseling sessions delivered by a social worker or similar healthcare professional (4 sessions, 2 hours total). The difference between arms will be in the frequency and duration of personalized nutrition counseling delivered by a registered dietitian or similar healthcare professional: 16 sessions (60 minutes per session), 12 sessions (60 minutes per session), 9 sessions (60 minutes per session), 8 sessions (45 minutes per session), or 6 sessions (30 minutes per session).
Study NCT06655324 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: V350A
Description: Vaccination administered via intramuscular injection
Study NCT06655324 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: V350B
Description: Vaccination administered via intramuscular injection
Study NCT06655324 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Vaccination administered via intramuscular injection
Study NCT06660732 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rilonacept
Description: 320 mg subcutaneous (SC) loading dose delivered as two 2-mL, subcutaneous injections of 160 mg on the same day at different anatomical sites followed by once weekly 160 mg SC doses.
Study NCT06670768 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Stress Dynamic MPI SPECT
Description: BMI standardized radiopharmaceutical injection in pharmacological stress (dipyridamole or adenosine) is performed under the SPECT camera to record the temporal distribution of the activity. A one-day protocol and multi-pinhole collimator are used.
Study NCT06670768 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Stress Static MPI SPECT
Description: 30-60 minutes after stress dynamic SPECT imaging is performed, an ECG-gated static SPECT MPI is conducted with a conventional LEHR collimator.
Study NCT06670768 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Rest Dynamic MPI SPECT
Description: 3 hours after the stress phase, the rest phase is also recorded. A radiopharmaceutical injection with a three-fold dose at rest is performed under the SPECT camera to record the temporal distribution of the activity. A one-day protocol and multi-pinhole collimator are used.
Study NCT06670768 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Rest Static MPI SPECT
Description: 30-60 minutes after rest, dynamic SPECT imaging is performed, and an ECG-gated static SPECT MPI is conducted with a conventional LEHR collimator.
Study NCT06670768 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Cardiac CT
Description: Within 30 days of MPI SPECT imaging, a cardiac CT is performed for every patient, including a native calcium-scoring scan and a coronary CT angiography as a reference standard. A photon-counting detector CT is used.
Study NCT05150925 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Cast treatment
Description: Dorsal cast placed in OR
Study NCT05150925 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Immediate mobilization
Description: Immediate mobilization postoperatively without casting
Study NCT05150925 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Volar plating
Description: Volar plating of distal radius fracture
Study NCT05150925 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Volar plating
Description: Volar plating of distal radius fracture
Study NCT06516289 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HRS-1167
Description: a highly selective PARP1 inhibitor
Study NCT06516289 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Famitinib
Description: a tyrosine kinase inhibitor targeting VEGFR2, PDGFR, and c-kit
Study NCT06516289 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Camrelizumab
Description: a humanised anti-programmed death-1 (anti PD-1) antibody
Study NCT06668025 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MxA tests
Description: Whole blood samples will be collected on Days 1, 4, 7, and 10 for MxA testing. MxA measurements on Days 4, 7, and 10 will be performed only for patients still hospitalized on antiviral thearpy or at the attending physician's discretion.